CDKN2A and Patent ductus arteriosus: Although PDA shows histological and clinical heterogeneity, the studies suggest that the majority of PDA expresses a successive accumulation of highly penetrant genetic changes at genetic genes such as K-ras, p53, CDKN2A and smad4/DPC46 as well as epigenetic alterations1.